Literature DB >> 8612390

Inhibition of tacrine oral clearance by cimetidine.

S T Forgue1, P A Reece, A J Sedman, T M deVries.   

Abstract

Plasma tacrine, 1-hydroxytacrine, 2-hydroxytacrine, and 4-hydroxytacrine concentrations were measured in 12 healthy elderly subjects in this nonblinded two-period study to assess the effect of multiple doses of cimetidine on single-dose tacrine pharmacokinetics. Subjects received 40 mg tacrine (Cognex) alone and during multiple-dose cimetidine (300 mg four times a day) administration. Overall, tacrine and cimetidine were well tolerated by healthy elderly subjects. After coadministration of cimetidine with tacrine, plasma tacrine concentrations were approximately one-third higher than values after administration of tacrine alone; metabolite concentrations were also higher. Mean tacrine oral clearance was reduced by 30%; however, mean absorption rate and elimination half-life values were not affected by cimetidine. It was concluded that cimetidine inhibits first-pass hepatic extraction of tacrine by cytochrome P450 enzymes but has little effect on systemic drug clearance. Clinical considerations may dictate a reduction in tacrine dosage when tacrine is coadministered with cimetidine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612390     DOI: 10.1016/S0009-9236(96)90114-9

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Grutzendler; J C Morris
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Drug interactions with cholinesterase inhibitors.

Authors:  Jennifer L Defilippi; M Lynn Crismon
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.

Authors:  Michael W Jann; Kara L Shirley; Gary W Small
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration.

Authors:  P J Tiseo; S L Rogers; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

5.  Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses.

Authors:  P J Tiseo; C A Perdomo; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

6.  Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease.

Authors:  R J Fontana; T M deVries; T F Woolf; M J Knapp; A S Brown; L S Kaminsky; B K Tang; N L Foster; R R Brown; P B Watkins
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

Review 7.  Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

Authors:  Danièle Bentué-Ferrer; Olivier Tribut; Elisabeth Polard; Hervé Allain
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.